(Q51988506)

English

Studies using a viral challenge and CD8 T cell depletions on the roles of cellular and humoral immunity in the control of an SHIV-89.6P challenge in DNA/MVA-vaccinated macaques.

scientific article published on 26 September 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16185742

Studies using a viral challenge and CD8 T cell depletions on the roles of cellular and humoral immunity in the control of an SHIV-89.6P challenge in DNA/MVA-vaccinated macaques. (English)

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16185742

David C. Montefiori

4

object named as

David C Montefiori

1 reference

Europe PubMed Central

19 April 2018

1

object named as

Rama Rao Amara

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16185742

Francois Villinger

3

object named as

Francois Villinger

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16185742

Harriet L Robinson

9

object named as

Harriet L Robinson

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16185742

author name string

Chris Ibegbu

2

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16185742

Sunita Sharma

5

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16185742

Pragati Nigam

6

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16185742

Yongxian Xu

7

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16185742

Harold M McClure

8

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16185742

language of work or name

0 references

publication date

26 September 2005

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16185742

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16185742

343

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16185742

2

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16185742

246-255

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16185742

Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

CD8 lethargy in the absence of CD4 help.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Skewed maturation of memory HIV-specific CD8 T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

HIV preferentially infects HIV-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: comparison of one- versus two-enzyme systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Effector and memory T-cell differentiation: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Vaccine protection against functional CTL abnormalities in simian human immunodeficiency virus-infected rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Neutralizing antibodies as a potential secondary protective mechanism during chronic SHIV infection in CD8+ T-cell-depleted macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Signature for long-term vaccine-mediated control of a Simian and human immunodeficiency virus 89.6P challenge: stable low-breadth and low-frequency T-cell response capable of coproducing gamma interferon and interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Slowly declining levels of viral RNA and DNA in DNA/recombinant modified vaccinia virus Ankara-vaccinated macaques with controlled simian-human immunodeficiency virus SHIV-89.6P challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Adoptive transfer of simian immunodeficiency virus (SIV) naïve autologous CD4(+) cells to macaques chronically infected with SIV is sufficient to induce long-term nonprogressor status

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.08.027

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2005.08.027

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16185742

release_26rcgcepebfkrfuz4ixfjusvcy

1 reference

https://api.fatcat.wiki/v0/release/26rcgcepebfkrfuz4ixfjusvcy

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16185742

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51988506&oldid=2137567898"